MétaCan
Menu
Back to cohort
Record W4415654614 · doi:10.1177/13524585251389797

Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis

2025· article· en· W4415654614 on OpenAlexaff
Tjalf Ziemssen, Mark S. Freedman, Amit Bar‐Or, Xavier Montalbán, Charlotte E. Teunissen, Dieter A. Häring, Petra Kukkaro, Martin Merschhemke, Bernd C. Kieseier, Meghana Karnik‐Henry, M. Gee, Sascha Lange, Eddine Merabet, Tanuja Chitnis, Stefan Bittner, Heinz Wiendl, Stephen L. Hauser

Bibliographic record

VenueMultiple Sclerosis Journal · 2025
Typearticle
Languageen
FieldMedicine
TopicMultiple Sclerosis Research Studies
Canadian institutionsOttawa HospitalUniversity of Ottawa
FundersJanssen PharmaceuticalsEMD SeronoMedDay PharmaceuticalsSiemens HealthineersSchweizerische Multiple Sklerose GesellschaftEisaiBundesministerium für Bildung und ForschungAtara BiotherapeuticsNational Institutes of HealthMylanTG TherapeuticsNovartis Pharmaceuticals CorporationMultiple Sclerosis SocietyEuropean Committee for Treatment and Research in Multiple SclerosisGrifolsF. Hoffmann-La RocheAlexion PharmaceuticalsBayer HealthCareNovartis PharmaEuropean CommissionEli Lilly and CompanyU.S. Department of DefenseMultiple Sclerosis International FederationGemeinnützige Hertie-StiftungSanofiNeuraxpharmTeva Pharmaceutical IndustriesNovartisCelgeneBiogenDeutsche ForschungsgemeinschaftGenentechNational Multiple Sclerosis SocietyGlaxoSmithKlineAstraZenecaSamsungBristol-Myers Squibb
KeywordsMultiple sclerosisDiseaseCentral nervous system diseaseDegenerative diseaseAmyotrophic lateral sclerosisClinical neurology

Abstract

fetched live from OpenAlex

BACKGROUND: Neurofilament light chain (NfL) is a promising marker for predicting disease activity in relapsing multiple sclerosis (RMS). To date, however, there has been no commercially available NfL assay validated in MS and intended for routine clinical use. OBJECTIVE: IM NfL assay. METHODS: The optimal NfL threshold for this assay/use case was identified and independently validated using ASCLEPIOS I and II data, respectively. The primary endpoint (annualized number of new/enlarging T2 (neT2) lesions) was analyzed using negative binomial models. Threshold optimization used maximum likelihood methodology. Generalizability analyses used data from ASCLEPIOS II, FREEDOMS, and TRANSFORMS. RESULTS: NfL concentration of 12.9 pg/mL was validated as the optimal cutoff for prognosticating disease activity as measured by neT2 lesion over 2 years. This threshold prognosticated individual patient risk for persistent disease activity (>3 neT2 lesions/year over 2 years) and showed prognostic value across relevant subgroups and clinical scenarios. Findings for relapses were similar. CONCLUSION: IM NfL assay is now validated for prognostic use in RMS patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.030
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.223
Threshold uncertainty score0.978

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0040.030
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.111
GPT teacher head0.343
Teacher spread0.232 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueMultiple Sclerosis JournalSame topicMultiple Sclerosis Research StudiesFrench-language works237,207